Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-1559. Abstract Telmisartan Randomized AssessmeNt ...
Angiotensin-converting enzyme (ACE) inhibitors are widely prescribed for patients with diabetes as a nephroprotector drug or to treat hypertension. ...
There is some evidence from clinical studies that ramipril or losartan not only significantly reduce cardiovascular events but they may also reduce the ...
The MICRO-HOPE (Lancet 2000;355:253-259) study suggested that angiotensin-converting enzyme inhibitor therapy with ramipril in diabetics is associated with ...
Novartis gained approvals in Japan for six new medicines, while three more approvals were received in January 2010 for Equa (Galvus), Exforge (hypertension) ...
